Recombinant growth hormone therapy for X-linked hypophosphatemia in children

Overview of attention for article published in Cochrane database of systematic reviews, October 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 1 news outlet

twitter: 1 tweeter

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 45 Mendeley

Summary News Twitter Dimensions citations

So far, Dimensions has found 3 publications that cite this research output.

3

The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.

Asia‐Pacific Consensus Recommendations on X‐Linked Hypophosphatemia: Diagnosis, Multidisciplinary Management, and Transition From Pediatric to Adult Care

Article in JBMR Plus (May 2023)

Growth hormone therapy in HHRH

Article in Bone Reports (May 2022)

Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia

Article in Nature Reviews Endocrinology (April 2022)